EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

UBC9-Mediated SUMO Pathway Drives Prohibitin-1 Nuclear Accumulation and PITX1 Repression in Primary Osteoarthritis

Roxanne Doucet, Abdellatif Elseoudi, Bita Rostami-Afshari, Mohamed Elbakry iD, Maryam Taheri, Martin Pellicelli, Cynthia Picard, Jean-François Lavoie, Da Shen Wang, Patrick Lavigne, Kristen F Gorman, Wesam Elremaly iD und 1 weitere

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms26136281 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Roxanne Doucet und 12 weiteren Autor:innen. Beteiligte Einrichtung: Viscogliosi Laboratory in Molecular Genetics of Musculoskeletal Diseases, Azrieli Research Center, CHU Sainte-Justine, Montreal, QC H3T 1C5, Canada. Hauptthemen laut MEDLINE: Repressor Proteins, Ubiquitin-Conjugating Enzymes, Paired Box Transcription Factors, Cell Nucleus. Die Arbeit nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: CIHR, Arthritis Society, Fonds de Recherche du Québec - Santé.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Osteoarthritis (OA) is a prevalent and debilitating joint disease in older adults with a complex etiology. We investigated the role of SUMOylation, a post-translational modification, in OA pathogenesis, focusing on the mitochondrial chaperone Prohibitin (PHB1) and the cartilage homeostasis transcription factor PITX1. We hypothesized that oxidative stress-induced SUMOylation promotes PHB1 nuclear accumulation, leading to PITX1 downregulation and contributing to OA development. Analysis of cartilage specimens from 27 OA patients and 4 healthy controls revealed an increased nuclear accumulation of PHB1 in OA chondrocytes, accompanied by elevated levels of SUMO-1 and SUMO-2/3. Mechanistically, nuclear PHB1 interacted indirectly with SUMO-1 through a SUMO-interacting motif (SIM), and the deletion of this SIM prevented PHB1 nuclear trapping in OA cells. Furthermore, the SUMO-conjugating enzyme E2 (UBC9) encoded by the UBE2I gene was upregulated in knee OA cartilage, and its overexpression in vitro enhanced PHB1 nuclear accumulation. Consistently, transgenic mice overexpressing the Ube2i gene exhibited increased UBC9 in their knee cartilage, resulting in Pitx1 downregulation and the emergence of an early OA-like phenotype in articular chondrocytes. Our findings uncover a novel role for UBC9-mediated SUMOylation in primary knee and hip OA. This pathway enhances PHB1 nuclear accumulation, contributing to PITX1 repression and subsequent OA development. These results underscore the importance of SUMOylation in OA pathogenesis and suggest potential molecular targets for early diagnosis and therapeutic intervention.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Repressor ProteinsUbiquitin-Conjugating EnzymesPaired Box Transcription FactorsCell NucleusOsteoarthritisSUMO-1 ProteinProhibitinsHumansAnimalsChondrocytesMiceSumoylationUbiquitin-Conjugating Enzyme UBC9MaleFemaleMice, TransgenicAgedMiddle AgedCartilage, Articular

Stichwörter der Autor:innen

PITX1Prohibitin-1 (PHB1)SUMOylationUBC9osteoarthritis

Substanzen

ProhibitinsRepressor ProteinsPHB protein, humanUbiquitin-Conjugating EnzymesUbiquitin-Conjugating Enzyme UBC9homeobox protein PITX1Paired Box Transcription FactorsSUMO-1 Protein

Autor:innen und Institutionen

  • Viscogliosi Laboratory in Molecular Genetics of Musculoskeletal Diseases, Azrieli Research Center, CHU Sainte-Justine, Montreal, QC H3T 1C5, Canada.
  • Program of Molecular Biology, Faculty of Medicine, Université de Montréal, Montreal, QC H3T 1J4, Canada.
  • Department of Biochemistry and Molecular Medicine, Faculty of Medicine, Université de Montréal, Montreal, QC H3T 1J4, Canada.
  • Biochemistry Division, Chemistry Department, Faculty of Science, Tanta University, Tanta 31527, Gharbia Governorate, Egypt.
  • Department of Surgery, Faculty of Medicine, Université de Montréal, Montreal, QC H3T 1J4, Canada.
  • Orthopedic Division, Maisonneuve-Rosemont Hospital, Montreal, QC H1T 2M4, Canada.

ORCID-Profile: Mohamed Elbakry, Wesam Elremaly

Förderung

  • CIHR
  • Arthritis Society
  • Fonds de Recherche du Québec - Santé
  • CHU Sainte-Justine Foundation
  • Canadian Institutes of Health Research
  • Arthritis Society Canada Ignite Innovation
  • Arthritis Society Postdoctoral Fellowship
  • FRSQ Master’s Scholarship Award

Zitieren

APA

Doucet, R., Elseoudi, A., Rostami-Afshari, B., Elbakry, M., Taheri, M., Pellicelli, M., Picard, C., Lavoie, J. F., Wang, D. S., Lavigne, P., Gorman, K. F., Elremaly, W., & Moreau, A. (2025). UBC9-Mediated SUMO Pathway Drives Prohibitin-1 Nuclear Accumulation and PITX1 Repression in Primary Osteoarthritis. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26136281

Vancouver

Doucet R, Elseoudi A, Rostami-Afshari B, Elbakry M, Taheri M, Pellicelli M, et al. UBC9-Mediated SUMO Pathway Drives Prohibitin-1 Nuclear Accumulation and PITX1 Repression in Primary Osteoarthritis. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26136281

BibTeX
@article{Doucet2025,
  author = {Doucet, Roxanne and Elseoudi, Abdellatif and Rostami-Afshari, Bita and Elbakry, Mohamed and Taheri, Maryam and Pellicelli, Martin and Picard, Cynthia and Lavoie, Jean-François and Wang, Da Shen and Lavigne, Patrick and Gorman, Kristen F and Elremaly, Wesam and Moreau, Alain},
  title = {UBC9-Mediated SUMO Pathway Drives Prohibitin-1 Nuclear Accumulation and PITX1 Repression in Primary Osteoarthritis},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms26136281}
}
Kostenlos starten →